Alliancebernstein L.P. Assembly Biosciences, Inc. Transaction History

Alliancebernstein L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$3.8 - $4.56 $97,280 - $116,735	-25,600 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$4.33 - $6.63 $18,619 - $28,509	-4,300 Reduced 14.38%	25,600 $118,000
Q3 2020 Nov 12, 2020	SELL	$15.08 - $27.04 $12,064 - $21,632	-800 Reduced 2.61%	29,900 $492,000
Q3 2019 Nov 14, 2019	BUY	$9.83 - $14.82 $24,575 - $37,050	2,500 Added 8.87%	30,700 $302,000
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $89,010 - $143,520	6,900 Added 32.39%	28,200 $380,000
Q1 2019 May 14, 2019	BUY	$17.7 - $24.93 $24,780 - $34,902	1,400 Added 7.04%	21,300 $419,000
Q2 2018 Aug 13, 2018	BUY	$39.21 - $50.29 $31,368 - $40,232	800 Added 4.19%	19,900 $780,000
Q1 2018 May 14, 2018	BUY	$41.7 - $64.16 $296,070 - $455,536	7,100 Added 59.17%	19,100 $939,000
Q4 2017 Feb 13, 2018	BUY	$28.58 - $49.91 $342,960 - $598,920	12,000	12,000 $543,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $723M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.